The therapeutic environment for patients with epidermal growth factor receptor mutations has been revolutionized by tagrisso, which is a precision treatment for adenocarcinoma (adenocarcinoma).However, one of the significant concerns associated with the use of tagrisso is the potential for QT interval prolongation, which is a condition that can lead to critical heart arrhythmias.This article aims to comprehensively investigate tagrisso-induced QT interval prolongation, investigating its elements, medical significance, and control methods.I. elements by which tagrisso can cause QT interval prolongationA. Overview of QT interval prolongationB. The effect of tagrisso on heart…
